13 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party
8-K
EX-10.1
URGN
UroGen Pharma Ltd
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation.
(d) If the indemnification provided
8-K
EX-10.1
URGN
UroGen Pharma Ltd
21 Mar 22
UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results
8:11am
be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative
8-K
EX-10.2
4neb 9b5nb32s7bq5q
9 Sep 20
Departure of Directors or Certain Officers
8:02am
S-3
EX-1.1
820zmmieaca16aq
20 Dec 19
Shelf registration
4:17pm
10-K
EX-10.11
csehd2lxwxox6r
28 Feb 19
Annual report
1:08pm
10-K
EX-10.10
3wty4cd oh154tz
28 Feb 19
Annual report
1:08pm
10-K
EX-10.9
x5ov 3y0u
28 Feb 19
Annual report
1:08pm
10-K
EX-10.14
4j4w9z7fq78xjr8b9x
28 Feb 19
Annual report
1:08pm
8-K
EX-1.1
eg5th
25 Jan 19
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
7:30am
F-3
EX-1.2
p2g0bnjo0w1syrj
12 Oct 18
Shelf registration (foreign)
5:24pm
- Prev
- 1
- Next